Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine

Hilda A. Namanja-Magliano, Kelsey Bohn, Neha Agrawal, Meghan E. Willoughby, Christine A. Hrycyna, Jean Chmielewski

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The brain provides a sanctuary site for HIV due, in part, to poor penetration of antiretroviral agents at the blood-brain barrier. This lack of penetration is partially attributed to drug efflux transporters such as P-glycoprotein (P-gp) and ABCG2. Inhibition of both ABCG2 and P-gp is critical for enhancing drug accumulation into the brain. In this work, we have developed a class of homodimers based on the HIV reverse transcriptase inhibitor azidothymidine (AZT) that effectively inhibits P-gp and ABCG2. These agents block transporter mediated efflux of the P-gp substrate calcein-AM and the ABCG2 substrate mitoxantrone. The homodimers function by interacting with the transporter drug binding sites as demonstrated by competition studies with the photo-affinity agent and P-gp/ABCG2 substrate [125I]iodoarylazidoprazosin. As such, these dual inhibitors of both efflux transporters provide a model for the future development of delivery vehicles for antiretroviral agents to the brain.

Original languageEnglish (US)
JournalBioorganic and Medicinal Chemistry
DOIs
StateAccepted/In press - 2017
Externally publishedYes

Fingerprint

Zidovudine
P-Glycoprotein
Blood-Brain Barrier
Antiviral Agents
Anti-Retroviral Agents
Brain
Pharmaceutical Preparations
Substrates
HIV Reverse Transcriptase
Mitoxantrone
Reverse Transcriptase Inhibitors
Binding Sites
HIV

Keywords

  • ABCG2
  • AZT
  • Blood-brain barrier
  • Inhibition
  • P-glycoprotein

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine. / Namanja-Magliano, Hilda A.; Bohn, Kelsey; Agrawal, Neha; Willoughby, Meghan E.; Hrycyna, Christine A.; Chmielewski, Jean.

In: Bioorganic and Medicinal Chemistry, 2017.

Research output: Contribution to journalArticle

Namanja-Magliano, Hilda A. ; Bohn, Kelsey ; Agrawal, Neha ; Willoughby, Meghan E. ; Hrycyna, Christine A. ; Chmielewski, Jean. / Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine. In: Bioorganic and Medicinal Chemistry. 2017.
@article{8ced2ff910a44c92816a03c37aabbd76,
title = "Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine",
abstract = "The brain provides a sanctuary site for HIV due, in part, to poor penetration of antiretroviral agents at the blood-brain barrier. This lack of penetration is partially attributed to drug efflux transporters such as P-glycoprotein (P-gp) and ABCG2. Inhibition of both ABCG2 and P-gp is critical for enhancing drug accumulation into the brain. In this work, we have developed a class of homodimers based on the HIV reverse transcriptase inhibitor azidothymidine (AZT) that effectively inhibits P-gp and ABCG2. These agents block transporter mediated efflux of the P-gp substrate calcein-AM and the ABCG2 substrate mitoxantrone. The homodimers function by interacting with the transporter drug binding sites as demonstrated by competition studies with the photo-affinity agent and P-gp/ABCG2 substrate [125I]iodoarylazidoprazosin. As such, these dual inhibitors of both efflux transporters provide a model for the future development of delivery vehicles for antiretroviral agents to the brain.",
keywords = "ABCG2, AZT, Blood-brain barrier, Inhibition, P-glycoprotein",
author = "Namanja-Magliano, {Hilda A.} and Kelsey Bohn and Neha Agrawal and Willoughby, {Meghan E.} and Hrycyna, {Christine A.} and Jean Chmielewski",
year = "2017",
doi = "10.1016/j.bmc.2017.07.001",
language = "English (US)",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine

AU - Namanja-Magliano, Hilda A.

AU - Bohn, Kelsey

AU - Agrawal, Neha

AU - Willoughby, Meghan E.

AU - Hrycyna, Christine A.

AU - Chmielewski, Jean

PY - 2017

Y1 - 2017

N2 - The brain provides a sanctuary site for HIV due, in part, to poor penetration of antiretroviral agents at the blood-brain barrier. This lack of penetration is partially attributed to drug efflux transporters such as P-glycoprotein (P-gp) and ABCG2. Inhibition of both ABCG2 and P-gp is critical for enhancing drug accumulation into the brain. In this work, we have developed a class of homodimers based on the HIV reverse transcriptase inhibitor azidothymidine (AZT) that effectively inhibits P-gp and ABCG2. These agents block transporter mediated efflux of the P-gp substrate calcein-AM and the ABCG2 substrate mitoxantrone. The homodimers function by interacting with the transporter drug binding sites as demonstrated by competition studies with the photo-affinity agent and P-gp/ABCG2 substrate [125I]iodoarylazidoprazosin. As such, these dual inhibitors of both efflux transporters provide a model for the future development of delivery vehicles for antiretroviral agents to the brain.

AB - The brain provides a sanctuary site for HIV due, in part, to poor penetration of antiretroviral agents at the blood-brain barrier. This lack of penetration is partially attributed to drug efflux transporters such as P-glycoprotein (P-gp) and ABCG2. Inhibition of both ABCG2 and P-gp is critical for enhancing drug accumulation into the brain. In this work, we have developed a class of homodimers based on the HIV reverse transcriptase inhibitor azidothymidine (AZT) that effectively inhibits P-gp and ABCG2. These agents block transporter mediated efflux of the P-gp substrate calcein-AM and the ABCG2 substrate mitoxantrone. The homodimers function by interacting with the transporter drug binding sites as demonstrated by competition studies with the photo-affinity agent and P-gp/ABCG2 substrate [125I]iodoarylazidoprazosin. As such, these dual inhibitors of both efflux transporters provide a model for the future development of delivery vehicles for antiretroviral agents to the brain.

KW - ABCG2

KW - AZT

KW - Blood-brain barrier

KW - Inhibition

KW - P-glycoprotein

UR - http://www.scopus.com/inward/record.url?scp=85023641268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023641268&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2017.07.001

DO - 10.1016/j.bmc.2017.07.001

M3 - Article

C2 - 28712845

AN - SCOPUS:85023641268

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

ER -